Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead Sciences Beats Q4 EPS Forecast
Gilead Sciences Beats Q4 EPS Forecast
Gilead Sciences Beats Q4 EPS Forecast
Submitted by
admin
on February 11, 2025 - 9:51pm
Source:
Motley Fool
News Tags:
Gilead Sciences
earnings
Headline:
Gilead Sciences Beats Q4 EPS Forecast
snippet:
Adjusted EPS of $1.90 topped analyst expectations of $1.74.
Q4 revenue reached $7.57 billion, surpassing forecasts of $7.15 billion.
HIV product sales showed substantial growth, climbing 16% to $5.5 billion due to high demand and inventory benefits.
Do Not Allow Advertisers to Use My Personal information
